Skip to content

A prospective randomized controlled trial of the effect of mahjong therapy (group therapy) on cognitive function of patients with mild cognitive impairment and early dementia

A prospective randomized controlled trial of the effect of mahjong therapy (group therapy) on cognitive function of patients with mild cognitive impairment and early dementia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056517
Enrollment
Unknown
Registered
2022-02-07
Start date
2022-02-28
Completion date
Unknown
Last updated
2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment (MCI) or early dementia (CDR<=1 point)

Interventions

Experimental group:Mahjong activity + drug therapy + music rhythm therapy
Control group:Drug therapy + music rhythm therapy

Sponsors

Changhe Tiancheng Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 50-85 years; 2. Progressive decline in cognitive function, in line with the diagnosis of DSM-V dementia (Dementia) or mild cognitive impairment (MCI); 3. CDR <= 1 point; 4. Have a certain ability to understand and express, and be able to obey most activity instructions; 5. No obvious physical impairment; 6. Accompanying family members or caregivers to participate in research activities; 7. Willingness to participate in research.

Exclusion criteria

Exclusion criteria: 1. Patients with rapidly progressive cognitive impairment whose disease course is less than half a year; 2. Patients with mental illness, such as severe depression, schizophrenia, etc.; 3. Severe hypertension, diabetes, unstable angina or uncontrolled hypertension and diabetes; 4. Severe visual impairment; 5. Serious acts of violence; 6. Unable to maintain sitting balance.

Design outcomes

Primary

MeasureTime frame
Changes from baseline in MMSE and MoCA scale scores after 12 weeks of treatment;

Secondary

MeasureTime frame
Proportion of patients with CDR <= 1;Changes from baseline in MemTrax and DSM-V cognitive domain involvement severity assessment after 12 weeks of treatment;Changes from baseline in ADSC-ADL after 12 weeks of treatment;Changes from baseline in NPI, HAMD, HAMA, and Apathy Rating Scale after 12 weeks of treatment;Change from baseline in caregiver burden after 12 weeks of treatment;Comparing different drugs combined with the same rehabilitation method, the difference in the efficacy of MCI and early dementia at 3 months;

Countries

China

Contacts

Public ContactHuang Weiping

Changhe Tiancheng Rehabilitation Hospital

weiping.huang@lih-rehab.com+86 15112390479

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026